Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01956435 · ClinicalTrials.gov registry record · NA

Excimer Light Treatment for Idiopathic Guttate Hypomelanosis: A Pilot Study

A NA study, sponsored by Seton Healthcare Family.

Completed
Registry status
NA
Development phase
6
Enrollment target

NCT01956435 is a NA study that has completed, run by Seton Healthcare Family. The registered enrollment target is 6 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01956435, a NA study, has completed, sponsored by Seton Healthcare Family.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target

Study Summary

This pilot study will consist of 10 adult subjects with symmetric idiopathic guttate hypomelanosis on the lower legs. Subjects will be randomized to which extremity (right or left) will be treated. Treatments with the Xtrac Excimer laser will be performed twice weekly for 12 weeks using the typical vitiligo protocol. Our goal is to determine the effectiveness of excimer laser for repigmentation of idiopathic guttate hypomelanosis. Effectiveness will be graded by the blinded observer scale via photographic comparisons and will be graded by subject via survey every 4 weeks.

Interventions

  • DEVICE Excimer Light Treatment

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2014-03
Est. Completion 2015-10
Phase NA

Sponsor

Seton Healthcare Family

15 total trials

What the Registry Record Tells You About NCT01956435

The ClinicalTrials.gov registry entry for NCT01956435 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seton Healthcare Family, which has 15 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Excimer Light Treatment is the first listed.

NCT01956435 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01956435 about?

NCT01956435 is a clinical study titled "Excimer Light Treatment for Idiopathic Guttate Hypomelanosis: A Pilot Study". This pilot study will consist of 10 adult subjects with symmetric idiopathic guttate hypomelanosis on the lower legs. Subjects will be randomized to which extremity (right or left) will be treated. Treatments with the Xtrac Excimer laser will be performed twice weekly for 12 weeks using the typical ...

What is the current status of trial NCT01956435?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2014-03. Estimated completion is 2015-10.

What interventions are being tested in trial NCT01956435?

The interventions under investigation include: Excimer Light Treatment (DEVICE).

Who is sponsoring clinical trial NCT01956435?

This trial is sponsored by Seton Healthcare Family, which has 15 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.